Valentina Ferrari

Milton Keynes, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3'-Deoxyadenosine, as a Potential Anticancer Agent.

Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3'-Deoxyadenosine, as a Potential Anticancer Agent.

Journal: Journal of medicinal chemistry

Published: November 23, 2022

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing.

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing.

Journal: Frontiers in oncology

Published: April 08, 2022

EANM guideline on quality risk management for radiopharmaceuticals.

EANM guideline on quality risk management for radiopharmaceuticals.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 18, 2022

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial.

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 06, 2021

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.

Journal: EJNMMI radiopharmacy and chemistry

Published: November 25, 2020

Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome.

Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome.

Journal: Cytotherapy

Published: July 08, 2020

In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.

In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.

Journal: Cytotherapy

Published: July 08, 2020

EANM guideline on the validation of analytical methods for radiopharmaceuticals.

EANM guideline on the validation of analytical methods for radiopharmaceuticals.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 11, 2019

Insula serotonin 2A receptor binding and gene expression contribute to serotonin transporter polymorphism anxious phenotype in primates.

Insula serotonin 2A receptor binding and gene expression contribute to serotonin transporter polymorphism anxious phenotype in primates.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 04, 2019

Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside Analogues.

Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside Analogues.

Journal: ChemMedChem

Published: July 27, 2018

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals.

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 01, 2017

Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?

Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?

Journal: Journal of medicinal chemistry

Published: September 09, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026